Short communication · 2020
ArticlePublished 2015
Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Most of the current therapies used in the treatment of multiple sclerosis (MS) are either ineffective or have adverse side effects. As such, there is a need to develop better therapies that specifically target myelin-specific aberrant immune cells involved in CNS inflammation without compromising the general immune system. In the present study, we developed a new bifunctional peptide inhibitor (BPI) that is effective and specific. Our BPI (PLP-B7AP) is composed of an antigenic peptide from myelin proteolipid protein (PLP139-151) and a B7 antisense peptide (B7AP) derived from CD28 receptor. The main hypothesis is that PLP-B7AP simultaneously targets MHC-II and B7-costimulatory molecules on the surface of antigen presenting cells (APC) and possibly alters the differentiation of naïve T cells from inflammatory to regulatory phenotypes. Results showed that PLP-B7AP was very effective in suppressing experimental autoimmune encephalomyelitis (EAE) compared to various controls in a mouse model. PLP-B7AP was effective when administered both before and after disease induction. Secreted cytokines from splenocytes isolated during periods of high disease severity and remission indicated that PLP-B7AP treatment induced an increased production of anti-inflammatory cytokines and inhibited the production of pro-inflammatory cytokines. Further, analysis of cortical brain tissue sections showed that PLP-B7AP treated mice had significantly lower demyelination compared to the control group. All these taken together indicate that the T cell receptor (TCR) and the CD28 receptor can be targeted simultaneously to improve efficacy and specificity of potential MS therapeutics.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Herbal a ameliorates experimental autoimmune encephalomyelitis by suppressing T cells and macrophage through NF-κB signaling pathway
Conference abstract
The role of NMDA receptor/NO signaling in tolerance, dependence and convulsant effects of methadone on clonic seizure in mice induced by pentylenetetrazole
Research article · 2012
Immuno-Informatic Speculation and Computational Modeling of Novel MHC-II Human Leukocyte Antigenic Alleles to Elicit Vaccine for Ebola Virus
Conference abstract · 20 Aug 2012
The route to tolerance induction and the role of MHC in future advances for organ transplantation
More from this journal
The newest in Journal of Multiple Sclerosis.
Article · 7 Apr 2026
A Link between Smoking and Age at Onset in Multiple Sclerosis
Article · 12 Feb 2026
Demyelination: Understanding the Disruption of Nerve Function
Article · 12 Feb 2026
Brain Tumors: Insights into Diagnosis, Management, and Future Perspectives
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Multiple Sclerosis
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Ahmed H Badawi”
- BylineArticles whose byline prints “Paul Kiptoo”
- BylineArticles whose byline prints “Teruna J Siahaan”

